Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GlaxoSmithKline acquires rights to Albugon

Oct. 29, 2004

CuraGen and Bayer advance diabetes compound into preclinical development

Oct. 29, 2004

Zometa receives Japanese approval

Oct. 28, 2004

Innodia begins phase I trial in Canada for ID-1101

Oct. 28, 2004

Arimoclomol demonstrates potential for type 2 diabetes

Oct. 28, 2004

SomatoKine designated orphan drug in Europe for extreme insulin resistance

Oct. 28, 2004

Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis

Oct. 27, 2004

Novel MCH receptor antagonists prepared and tested at Schering-Plough

Oct. 27, 2004

Therapeutic benefits of lasofoxifene in menopausal vaginal atrophy

Oct. 26, 2004

ARS scientists develop new prostanoid agonists for female infertility, asthma, etc.

Oct. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...